Lose weight first or reduce the breasts first? (And what happens if you are on Ozempic)

It is one of the phrases most often heard in clinic — “they told me to lose weight first” — and one of the most damaging when it is said with nothing else. Because behind it are two very different questions: whether losing weight will solve your problem and whether losing weight first makes the surgery safer. The answer to the first is almost always no. The answer to the second is “it depends, and not on what you think”.

This page answers both with the published figures, and includes what has changed the picture in recent years: GLP-1 drugs.

What happens to the breast when you lose weight

Until recently this was answered by ear. Now there are figures.

A 2024 Swedish study measured the breasts of 106 women before and after gastric bypass and built, for the first time, a reference for breast measurements in women with obesity. Two things came out of it.

The first: how much breast there is, according to weight.

The second, and the important one: what changes when you lose weight. With a 20% reduction in body mass index:

• breast volume falls by 25%,
• ptosis — the droop — improves by 20%,
• and the sternal notch-to-nipple distance shortens by only 4%.

That 4% is the figure nobody mentions. The breast loses content but does not regain position. What is left is a smaller, emptier breast with the same skin — that is, with more surplus skin than before.

Why that matters for your decision

If your problem is the weight of the breast — back and neck pain, bra strap grooves, rashes underneath — losing weight can help, and that has to be said: taking off 25% of the volume is no small thing. That picture is developed in breast hypertrophy and back pain.

If your problem is the shape — that the breast droops, that the nipple points downwards, that you cannot find clothes — losing weight will not solve it and, in many cases, it makes it more marked.

And there is a third scenario, the most frequent: both at once. There the question stops being “do I lose weight or have surgery?” and becomes “in what order and with what margin?”.

⚠️ An honest note about the order: if you are planning to lose a lot of weight, having surgery first means accepting that the breast will change afterwards, and that you might need a revision. If you have surgery afterwards, you arrive with laxer skin but with a more stable plan. Neither is “the right one”; they are two different costs.

The BMI requirement: what is asked and what the evidence says

Here it is worth being transparent, because it is one of the most repeated claims and one of the worst supported.

What is asked. In the survey of 513 French plastic surgeons published in 2026, the two most usual preoperative requirements were stopping smoking (89%) and a body mass index below 30 (79%). It is, without doubt, majority practice.

What the evidence says. Less clear than that 79% suggests:

• A study of 661 patients published in 2024 found that patients with obesity had more infections and more revisions (p < 0.01)… but that their satisfaction with the result was the same.
• A 2026 study of 99 patients concluded outright that body mass index was not independently associated either with complications or with satisfaction. What did predict complications was having respiratory disease (p = 0.007).
• And in the analysis of 1,021 patients from 2024, the only independent risk factor was not the patient’s weight but the weight of the tissue removed, with a threshold above 1,700 grams.

Honest conclusion: the BMI 30 threshold is a widespread and prudent practice, not a demonstrated fact. That someone is asked for it is reasonable; that it is presented to them as a law of nature is not. And it is certainly no reason not to go and be assessed.

If you are taking a GLP-1

Ozempic, Wegovy, Mounjaro and the rest have changed the picture in two years, and plastic surgery is running behind trying to catch up. What has been published to date:

The changes in the breast can be dramatic. A 2026 review specifically on aesthetic breast surgery after weight loss with GLP-1s warns that striking changes in the appearance of the breast can appear, including droop and asymmetry, and recommends planning the conversation with the patient before operating.

There is somewhat more risk of a wound complication. An analysis of a large national database, published in 2025 with matched cohorts, found in breast reduction 2.6% wound complications in GLP-1 users against 1.3% in non-users (p = 0.035). It is double in relative terms, but the absolute figures are worth reading: out of every 100 patients, a little more than one extra.

And compared with bariatric surgery, they come off well. In the study comparing the three groups, GLP-1 users were far closer to patients with no previous weight loss than to those who had had bariatric surgery.

⚠️ What is compulsory: saying so. These drugs slow gastric emptying, which directly affects preoperative fasting instructions and the anaesthetist’s judgement. It is not a cosmetic detail you can keep to yourself.

If you have had bariatric surgery

This is the scenario that calls for most care, and the figures say so without ambiguity.

A 2025 study compared 90 breast reduction patients across three groups matched for age, BMI and comorbidity: 30 GLP-1 users, 30 who had had bariatric surgery and 30 controls.

Major complications — those requiring reoperation — were low and similar in all groups (0%, 6.7% and 6.7%). What shot up was seroma (30% in the bariatric group) and skin necrosis, which appeared only in that group (13.3%).

🔑 But the most useful part of the study is the why. Multivariate analysis identified two independent factors: low albumin (OR 8.5) and a history of bariatric surgery (OR 15.6). And the preoperative albumin figures were different: 3.5 g/dl in the bariatric group against 4.0 in the GLP-1 group and 4.2 in controls.

In other words: the problem is not having lost weight, it is arriving in theatre poorly nourished. And that, unlike the weight lost, can be corrected before surgery.

So what do I do?

There is no universal rule, but there is a sensible way of ordering the conversation:

1. If your weight is stable, losing weight is not an automatic requirement. Get assessed.
2. If you are in the middle of losing weight, it makes sense to wait until you stabilise — not until you reach a magic number, but until the scales stop moving — because the breast will go on changing.
3. If you have had bariatric surgery, the important preparatory work is not losing more weight: it is blood tests and nutrition. Ask explicitly about albumin.
4. If you are on a GLP-1, say so at the first consultation and again at the pre-anaesthetic assessment.
5. If you have been told “lose weight first” and nothing else, you are entitled to ask why in your particular case and what would change.

What is asked here, specifically

🔑 Why stable weight is asked for, and not “lose weight first”. They are two different things and they get confused all the time. What matters is not arriving slim: it is that the scales have stopped moving. If you lose weight after surgery, the volume you were left with shrinks further — and as volume is lost, laxity and droop increase compared with the result that had been achieved. It is not that the result spoils: it is that it stops being the one that was agreed.

And if you are on a GLP-1

Surgery can be done while taking it. It is not a contraindication, but it changes two things:

• The recommendation is to have stopped it at least a month beforehand and to come to surgery with your weight stable since stopping, for the reason above.
• If you are operated on during treatment, high-protein intake has to be pushed. This is the part almost nobody mentions: these drugs greatly reduce how much you eat, and healing consumes protein. Having surgery while eating little and not compensating for it is what makes a wound slow.

⚠️ And the point about telling the pre-anaesthetic team still stands, which is a different matter — gastric emptying and fasting — not healing.

Frequently asked questions

If I lose weight, will my breasts get smaller?

Yes, in part. In the study that measured it, a 20% fall in body mass index went with a 25% reduction in breast volume. What barely changes is the position of the nipple: only 4%.

So can losing weight save me from surgery?

It can relieve the symptoms caused by weight, but it does not correct the shape. In fact, as volume is lost and the skin remains, the breast often ends up emptier and more droopy than before.

Is it true that I need a BMI under 30?

It is the requirement asked for by 79% of surgeons in a national survey, but the evidence is not unanimous: there are studies that find no independent relationship between body mass index and complications or satisfaction. It is a prudent practice, not a law.

I am on Ozempic, can I have surgery?

It is a conversation to have with the surgeon and the anaesthetist, not an answer from the internet. There is somewhat more risk of a wound complication — 2.6% against 1.3% — and, above all, these drugs affect gastric emptying and therefore fasting instructions.

I had bariatric surgery, am I at greater risk?

Yes, and notably so: in the comparative study, 63.3% of the bariatric group had some complication against 10% of controls. But the factor identified was low albumin, which is correctable before surgery.

Is it better to have surgery before or after losing weight?

If you are going to lose a lot of weight, having surgery first means accepting that the breast will change afterwards. Having surgery afterwards means arriving with more lax skin. They are two different costs and the decision is an individual one.

Sources

• Ockell J, et al. «Normal» breast dimensions in obese women — reference values and the effect of weight loss. J Plast Reconstr Aesthet Surg. 2024. One hundred and six women who underwent laparoscopic Roux-en-Y gastric bypass in Gothenburg (Sweden) were measured before and after bariatric surgery; breast volume, sternal notch-to-nipple distance and ptosis all increased significantly with body mass index (mean volume of approximately 770 ml at BMI 30-34.9 kg/m², 1,150 ml at BMI 40-44.9 kg/m² and 1,400 ml at BMI above 50 kg/m²); the percentage change in each measurement relative to the percentage change in BMI is predictable: with a 20% reduction in BMI, breast volume falls by 25%, sternal notch-to-nipple distance by 4% and ptosis by 20%. https://pubmed.ncbi.nlm.nih.gov/38810359/
• Friedman O, Tal D, et al. Breast reduction outcomes in massive weight loss: A comparative analysis of GLP-1 receptor agonist users, post-bariatric surgery patients, and controls. J Plast Reconstr Aesthet Surg. 2025. Retrospective cohort study of 90 patients who had a breast reduction between 2020 and 2024, stratified into three groups matched for age, body mass index and comorbidity: GLP-1 receptor agonist users (n = 30), post-bariatric surgery patients (n = 30) and controls (n = 30); major complications were low in all three groups (0%, 6.7% and 6.7%; p = 0.368), but overall complications requiring some intervention differed significantly (p < 0.001): controls 10.0%, GLP-1 users 23.3% and post-bariatric patients 63.3%; seroma was 3.3%, 16.7% and 30.0% respectively (p = 0.008) and skin necrosis appeared exclusively in the post-bariatric group (13.3%; p = 0.041); multivariate analysis identified hypoalbuminaemia (OR 8.5; p = 0.005) and a history of bariatric surgery (OR 15.6; p < 0.001) as independent risk factors, with preoperative albumin of 3.5 ± 0.2 g/dl in the post-bariatric group against 4.0 ± 0.2 in GLP-1 users and 4.2 ± 0.2 in controls (p < 0.001). https://pubmed.ncbi.nlm.nih.gov/41066871/
• Lee CC, et al. Impact of GLP-1 Agonist on Surgical Wound Complications Following Plastic and Reconstructive Surgery: A Propensity Matched Cohort Large Database Analysis. Plast Reconstr Surg. 2025. Query of the TriNetX national database to identify patients who had panniculectomy, abdominoplasty and breast reduction, excluding diabetes, peripheral vascular disease, nutritional, metabolic or endocrine disease, a history of cancer and smokers, with propensity score matching; the risk of surgical wound healing complications in GLP-1 agonist users was significantly higher both before and after matching: 4.7% against 2.7% in panniculectomy (p = 0.05), 9.8% against 3.6% in abdominoplasty (p = 0.001) and 2.6% against 1.3% in breast reduction (p = 0.035). https://pubmed.ncbi.nlm.nih.gov/41364427/
• Nahabedian MY, et al. GLP-1 Receptor Agonist-Associated Weight Loss and Aesthetic Breast Surgery: A Narrative Review and Experience-Based Recommendations for Plastic and Reconstructive Surgeons. Aesthet Surg J Open Forum. 2026. Narrative review of the literature on GLP-1 receptor agonists and other mechanisms of medical weight loss applied to aesthetic breast surgery, supplemented with two clinical cases; the authors note that dramatic changes in the appearance of the breast can occur after weight loss, including ptosis and asymmetry, and recommend considering overall weight, body composition and breast aesthetics and informing the patient before surgery, anticipating that surgical protocols and pre- and postoperative counselling recommendations will need to be updated as knowledge grows. https://pubmed.ncbi.nlm.nih.gov/41978571/
• Mortada H, Alosaimi K, Alsubhi MN, et al. Pilot Study: Impact of Obesity on Complications and Outcomes in Reduction Mammoplasty. Plast Reconstr Surg Glob Open. 2026;14:e7794. Retrospective review of 99 patients who had a breast reduction at King Khalid University Hospital between September 2015 and April 2024, categorised by body mass index; operating time differed significantly between BMI categories (p = 0.048), with longer times in the higher categories; late complications occurred in 24.2% of patients, the most frequent being wound dehiscence (54.2% of complications); on multivariate regression, respiratory comorbidity was a significant predictor of more complications (β = 0.93; p = 0.007), while body mass index was not significantly associated either with complication rates or with satisfaction scores. https://pubmed.ncbi.nlm.nih.gov/42232886/
• Park JB, Adebagbo OD, Rahmani B, et al. BREAST-Q Analysis of Reduction Mammaplasty: Do Postoperative Complications of Breast Reduction Surgery Negatively Affect Patient Satisfaction?. Aesthet Surg J. 2024;44:NP852-NP861. Retrospective review of 661 patients operated on by 13 surgeons between January 2017 and February 2023; the group with complications was on average older and had a higher body mass index, and was more likely to have hypertension and diabetes (p < 0.01); patients with obesity had more infections and more revisions (p < 0.01), but there were no significant differences in any of the BREAST-Q outcomes between those who had complications and those who did not. Level of evidence 3. https://pubmed.ncbi.nlm.nih.gov/39052922/
• Mahrhofer M, Wallner C, Reichert R, et al. Identifying complication risk factors in reduction mammaplasty: a single-center analysis of 1021 patients applying machine learning methods. Updates Surg. 2024;76:2943-2952. Resection weight was the only significant independent risk factor (OR 1.001; p = 0.007), with a threshold of 1,700 g of total resection above which the risk of complications increased significantly. https://pubmed.ncbi.nlm.nih.gov/39243317/
• Léger M, Vanaret J, Coquerel-Beghin D, Dhellemmes O, Martinot-Duquennoy V, Auquit-Auckbur I. Current practices in reduction mammaplasty: A nationwide survey of French plastic surgeons in 2024. Ann Chir Plast Esthet. 2026;71:343-350. Cross-sectional survey answered by 513 French plastic surgeons; the main preoperative requirements were stopping smoking (89%) and a body mass index below 30 kg/m² (79%). https://pubmed.ncbi.nlm.nih.gov/41688323/

Book your consultation

If you have been told “lose weight first” and been left with the feeling that it was a closed door, it is worth having someone explain what exactly would change in your case if you lost weight, and what would not.

And if you are coming from bariatric surgery or are on a GLP-1, the useful conversation does not start with the scales: it starts with a blood test.

Clinical confirmation by the surgeon

Dr Enrique Salmerón González

Specialist in Plastic, Aesthetic and Reconstructive Surgery
Registration no. 46/4624077

Dr Elena García Vilariño

Specialist in Plastic, Aesthetic and Reconstructive Surgery
Registration no. 46/4624503

Last reviewed: 6 September 2026. This content is for information only and does not replace an individual assessment by a healthcare professional.